Genentech's Giredestrant: First Oral SERD for Breast Cancer Survival
0:09
Genentech's Giredestrant: First Oral SERD for Breast Cancer Survival
104 views7 months ago
YouTubeMCQ Pedia
lidERA trial: giredestrant improves invasive disease-free survival in ER+/HER2- early breast cancer
3:01
lidERA trial: giredestrant improves invasive disease-free survival in ER+/HER2- early breast cancer
1K views10 months ago
YouTubeVJOncology
New Oral SERD Improves Outcomes in Adjuvant Breast Cancer Treatment
1:10
New Oral SERD Improves Outcomes in Adjuvant Breast Cancer Treatment
101 views6 months ago
YouTubeThe Oncology Brief
Giredestrant plus everolimus new treatment option in ER+, HER2– advanced breast cancer, post-CDK...
4:21
Giredestrant plus everolimus new treatment option in ER+, HER2– advanced breast cancer, post-CDK...
352 views8 months ago
YouTubeecancer
Let’s talk about lidERA trial which was presented at SABCS! This study tested whether the oral SERD (selective estrogen receptor degrader), giredestrant, is superior to current endocrine therapy as adjuvant therapy in ER /HER2 negative early stage breast cancer. Giredestrant binds to the estrogen receptor and induces a change in it that not only blocks the estrogen receptor but breaks it down as well. SERDs are approved in metastatic breast cancer but this is the first study in early stage breas
3:56
Let’s talk about lidERA trial which was presented at SABCS! This study tested whether the oral SERD (selective estrogen receptor degrader), giredestrant, is superior to current endocrine therapy as adjuvant therapy in ER /HER2 negative early stage breast cancer. Giredestrant binds to the estrogen receptor and induces a change in it that not only blocks the estrogen receptor but breaks it down as well. SERDs are approved in metastatic breast cancer but this is the first study in early stage breas
24.4K views10 months ago
FacebookEleonora Teplinsky, MD
lidERA: giredestrant efficacy by menopausal status in ER+/HER2- breast cancer
4:24
lidERA: giredestrant efficacy by menopausal status in ER+/HER2- breast cancer
265 views4 months ago
YouTubeVJOncology
What is Giredestrant? A Revolution in Hormone-Positive Breast Cancer Treatment 🎉 Coming Soon! 👯 C...
8:33
What is Giredestrant? A Revolution in Hormone-Positive Breast Cancer Treatment 🎉 Coming Soon! 👯 C...
29.7K views2 weeks ago
YouTube닥터BTS의 유선방송
1:07
New Oral SERD Shows Promise in Early Breast Cancer Treatment
26 views5 months ago
YouTubeOncology Perspectives
0:09
Dr. Amit Garg 🩸 on Instagram: "Roche revealed that giredestrant — an oral selective-estrogen receptor degrader (SERD) — cut the risk of breast-cancer recurrence by 30% compared with standard endocrine therapy in early-stage disease #cancer #breastcancer"
91.2K views10 months ago
Instagramblooddocdad
4:39
A major update from SABCS: BCRF investigator Dr. Aditya Bardia shares encouraging results from the lidERA trial, studying a new hormone therapy called giredestrant for early HR breast cancer. In the trial, giredestrant lowered the risk of cancer coming back and showed fewer treatment-related side effects, meaning it may be both more effective and easier to stay on than current options. If approved, it could become the first new adjuvant endocrine therapy in decades. FDA review is expected in 202
11.4K views10 months ago
FacebookThe Breast Cancer Research Foundation
3:03
Replying to @Vicky 🎥 Can you switch from anastrozole to giredestrant? So many of you asked this — especially those in surgical menopause currently taking aromatase inhibitors like anastrozole. Here’s what we know so far ⬇️ 🧬 Giredestrant is a new oral SERD (Selective Estrogen Receptor Degrader) that’s being studied as initial adjuvant therapy — meaning it was started shortly after surgery, not as a switch from anastrozole. As of now, there’s no trial data on whether it’s safe or effective to s
1.7K views9 months ago
TikTokjasvir.kaur.pharmd
0:46
Are Oral SERDs Better Than Standard Therapy in Breast Cancer?
130 views5 months ago
YouTubeCancerNetwork
1:13
Combining Ribociclib & Abemaciclib with Giredestrant - More Data Needed?
97 views5 months ago
YouTubeInnovative Oncology News
0:45
62% Improvement in PFS – evERA Breast Cancer Study Update
442 views11 months ago
YouTubeTargeted Oncology
0:41
Oral SERDs Impacting Breast Cancer Treatment #shorts
381 views8 months ago
YouTubeCancer Treatment Updates
0:39
🚨 Roche Reports evERA Phase III Trial | Can Giredestrant + Everolimus Change Breast Cancer Care?
389 viewsSep 25, 2025
YouTubeOncoAlert 360
1:31
EMPRESS: giredestrant vs tamoxifen in ER+/HER2- early breast cancer
185 views11 months ago
YouTubeVJOncology
4:51
Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2-negative metastatic bre...
25 views2 months ago
YouTubeecancer
Giredestrant vs Standard-of-Care Endocrine Therapy as Adjuvant Treatment for Patients with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer: Results From the Global Phase III lidERA Breast Cancer Trial | OncLive
8 months ago
onclive.com
2:40
Trending in Women’s Health: Giredestrant, Iza-bren and More
3 views4 months ago
YouTubeLucidQuest
6:21
PREcoopERA: Are endocrine therapy strategies changing with giredestrant?
41 views4 months ago
YouTubeOncoInfoTV
26:52
Early Stage Hormone Receptor Positive (HR+) Breast Cancer Treatment Algorithm: Dr. Erica Mayer
7.6K views8 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discussions
1:36
How to treat GERD
3.2K views10 months ago
YouTubeLoyola Medicine
4:36
HR+ Breast Cancer: Inavolisib First -Line Use and Emerging Adjuvant Oral SERDs
1.3K views9 months ago
YouTubeOncUpdates: Latest Oncology Insights
9:55
3 Breast Cancer Trials That Will Change Care in 2026
4.7K views9 months ago
YouTubeCancer Treatment Updates
1:44
PREcoopERA: giredestrant versus anastrozole in ER+/HER2- early breast cancer
403 viewsMay 17, 2024
YouTubeVJOncology
4:45
Giredestrant plus palbociclib vs anastrozole plus palbociclib for post-menopausal, HER2-negative...
1.5K viewsSep 30, 2021
YouTubeecancer
2:46
Women's Health Update – 10 Jun 2026: Giredestrant, Iza-bren and More
16 views4 months ago
YouTubeLucidQuest
4:24
Oncology Update – 02 Mar 2026: FDA Full Approval for BRAFTOVI, FDA Accepts Giredestrant NDA and More
31 views7 months ago
YouTubeLucidQuest
0:31
ASCO 2026 — Breast & GU Cancer Top Trials
111 views4 months ago
YouTubeCancer Care Tools
See more
Static thumbnail place holder
You may also want to search